Home Stock

Stock Research: Dis-Chem Pharmacies

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Dis-Chem Pharmacies

JNB:DCP ZAE000227831
9
  • Value
    39
  • Growth
    19
  • Safety
    Safety
    45
  • Combined
    19
  • Sentiment
    21
  • 360° View
    360° View
    9
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Dis-Chem Pharmacies Limited is a South Africa-based company retailing and wholesaling affordable healthcare products and pharmaceuticals. It operates in the retail and wholesale industries. The company operates in South Africa. In the last fiscal year, the company had a market cap of $1,546 million, profits of $472 million, and revenue of $2,100 million. The number of employees is not available.

more

ANALYSIS: With an Obermatt 360° View of 9 (better than 9% compared with alternatives), overall professional sentiment and financial characteristics for the stock Dis-Chem Pharmacies are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Dis-Chem Pharmacies. The consolidated Value Rank has a low rank of 39 which means that the share price of Dis-Chem Pharmacies is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 61% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 19, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 19% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 45, which means that the company has a riskier financing structure than 55% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 21, which means that professional investors are more pessimistic about the stock than for 79% of alternative investment opportunities. ...read more

more
Strongest Rank Opinions Change
Weakest Rank Pro Holdings
Country South Africa
Industry Drug Retail
Size Medium
Website dischemgroup.com
Index
JSE All Shares
Dis-Chem Pharmacies stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 11-Nov-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
39 15 23 23
Growth
19 97 57 53
Safety
Safety
45 47 56 38
Sentiment
21 70 27 43
360° View
360° View
9 75 28 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
21 70 54 17
Opinions Change
7 50 29 50
Pro Holdings
n/a 83 31 65
Market Pulse
17 41 40 52
Sentiment
21 70 27 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
39 15 23 23
Growth
19 97 57 53
Safety Safety
45 47 56 38
Combined
19 57 36 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
58 49 50 43
Price vs. Earnings (P/E)
27 25 31 33
Price vs. Book (P/B)
35 15 18 13
Dividend Yield
45 32 39 33
Value
39 15 23 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
62 86 70 56
Profit Growth
22 74 44 50
Capital Growth
42 96 41 17
Stock Returns
18 69 55 85
Growth
19 97 57 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
27 31 36 28
Refinancing
67 52 53 51
Liquidity
29 57 60 47
Safety Safety
45 47 56 38

Similar Stocks

Discover high‑ranked alternatives to Dis-Chem Pharmacies and broaden your portfolio horizons.

Caxton and CTP Publishers and Printers

JNB:CAT
Country: South Africa
Industry: Publishing
Size: Medium
Full Stock Analysis

Sanlam

JNB:SLM
Country: South Africa
Industry: Life & Health Insurance
Size: Large
Full Stock Analysis

Puregold Price Club

PHS:PGOLD
Country: Philippines
Industry: Hypermarkets, Super Centers
Size: Large
Full Stock Analysis

Telkom

JNB:TKG
Country: South Africa
Industry: Integrated Telecommunication
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews